Eldon C. Mayer III Insider Trading
Get free email notifications about insider trading for Eldon C. Mayer III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eldon C. Mayer III. Eldon C. Mayer III is a EVP & Chief Commercial Officer in RIGEL PHARMACEUTICALS INC ($RIGL) and a EVP &Chief Commercial Officer in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and a Ex VP & Chief Commerc. Officer in Eiger BioPharmaceuticals, Inc. ($EIGR).
Address: RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO 94080 CA
Companies in which Eldon C. Mayer III is an Insider
Eiger BioPharmaceuticals, Inc.
Trading Symbol: EIGRIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Eldon C. Mayer III: Ex VP & Chief Commerc. Officer, Director
Holdings: 47,685 shares
Current Value: $553,146
Latest Transaction: Mar 15 2021
$EIGR Market Capitalization: $93.59M
$EIGR Previous Close: $11.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Trading Symbol: RIGLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eldon C. Mayer III: EVP & Chief Commercial Officer, EVP &Chief Commercial Officer
Holdings: 165,000 shares
Current Value: $404,250
Latest Transaction: Nov 20 2019
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Eldon C. Mayer III
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Option Exercise | A | 9.99 | 71,250 | 711,788 | 71,250 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Grant | A | 0.00 | 11,875 | 0 | 47,685 | 35.8 K to 47.7 K (+33.16 %) |
Jan 11 2021 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Sell | S | 11.68 | 1,690 | 19,739 | 35,810 | 37.5 K to 35.8 K (-4.51 %) |
Jan 31 2020 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Option Exercise | A | 12.36 | 150,000 | 1,854,000 | 150,000 | |
Jan 31 2020 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Grant | A | 0.00 | 7,500 | 0 | 37,500 | 30 K to 37.5 K (+25.00 %) |
Jan 30 2020 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Buy | P | 13.52 | 5,000 | 67,603 | 30,000 | 25 K to 30 K (+20.00 %) |
Nov 20 2019 | RIGL | RIGEL PHARMACEUTIC ... | Mayer Eldon C. III | EVP & Chief Commerc ... | Option Exercise | A | 4.49 | 75,000 | 336,750 | 75,000 |